| DIRECT COMPETITOR COMPARISON | |
| CYTK | AMGN | NBIX | PDLI | Industry | | Market Cap: | 204.11M | 57.77B | 85.47M | 1.00B | 99.24M | | Employees: | 112 | 16,700 | 125 | 6 | 65 | | Qtrly Rev Growth (yoy): | 76.20% | -1.60% | -3.70% | 3.80% | 19.70% | | Revenue (ttm): | 83.67M | 14.58B | 2.94M | 328.67M | 14.01M | | Gross Margin (ttm): | 50.41% | 84.99% | N/A | 100.00% | 65.67% | | EBITDA (ttm): | 29.40M | 6.71B | -47.02M | 303.04M | -12.30M | | Oper Margins (ttm): | 32.65% | 38.71% | -1,740.48% | 90.55% | -137.11% | | Net Income (ttm): | 26.22M | 4.74B | -71.98M | 216.58M | N/A | | EPS (ttm): | 0.478 | 4.585 | -1.853 | 1.153 | -0.32 | | P/E (ttm): | 7.01 | 12.45 | N/A | 7.26 | 16.76 | | PEG (5 yr expected): | 0.53 | 1.32 | N/A | 0.26 | 1.32 | | P/S (ttm): | 2.48 | 3.94 | 28.92 | 2.89 | 9.68 |
|
| AMGN = Amgen Inc. | | NBIX = Neurocrine Biosciences Inc. | | PDLI = PDL BioPharma, Inc. | | Industry = Biotechnology | |
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.08 | 0.49% | 57.77B | 12.45 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.45 | 0.15% | 13.72B | 15.88 | | Genzyme Corp. | GENZ | 51.52 | 2.26% | 13.67B | 29.37 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.98 | 0.04% | 42.28B | 18.17 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.89 | 1.41% | 9.08B | 1038.57 | | Teva Pharmaceutical Industries Limited | TEVA | 53.16 | -0.21% | 46.83B | 48.64 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.81 | 2.05% | 4.01B | 19.49 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.08 | 0.00% | 3.00B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.29 | -0.05% | 5.59B | 112.21 | | Pfizer Inc. | PFE | 18.59 | 1.53% | 150.01B | 15.44 | | Johnson & Johnson | JNJ | 63.30 | 0.19% | 174.65B | 13.82 | | GlaxoSmithKline plc | GSK | 42.88 | 1.42% | 108.70B | 13.53 | | Sanofi-Aventis | SNY | 39.46 | 2.15% | 103.03B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.85 | 0.99% | 126.85B | 16.72 | | RHHBY.PK | 42.29 | 2.03% | N/A | N/A | | AstraZeneca plc | AZN | 46.38 | 2.50% | 67.25B | 9.31 | | Abbott Laboratories | ABT | 54.41 | 0.31% | 84.16B | 14.74 | | Bristol-Myers Squibb Co. | BMY | 25.65 | 1.95% | 50.81B | 13.27 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | PDLI | | PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure
Wed 4:53pm -
EDGAR Online | | • | AMGN | | Dream Stocks for Biotech Investors
Wed 3:27pm -
at Motley Fool | | • | AMGN | | Novartis Didn't Know JAK, Until Now
Wed 2:41pm -
at Motley Fool | | • | AMGN | | Beacon Equity Issues Technical Trading Overview for NexMed Inc.
Wed 6:50am -
GlobeNewswire | | • | AMGN | | [video] Topping the Tape
Tue, Nov 24 -
at CNBC | | • | AMGN | | Signals Favor a Santa Claus Rally
Tue, Nov 24 -
at Minyanville.com | | • | NBIX | | Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
Tue, Nov 24 -
PR Newswire | | • | PDLI | | PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Tue, Nov 24 -
EDGAR Online | | • | PDLI | | PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend
Mon, Nov 23 -
PR Newswire | | • | PDLI | | PDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Wed, Nov 18 -
EDGAR Online | | • | PDLI | | Klarman, Whitman Are Sellers But Witmer Buys in Q3 2009
Wed, Nov 18 -
at Seeking Alpha | | • | PDLI | | Five Dividend Stocks With Growth Potential
Mon, Nov 16 -
at Investopedia | | • | NBIX | | NEUROCRINE BIOSCIENCES INC Financials
Wed, Nov 4 -
EDGAR Online Financials | | • | NBIX | | NEUROCRINE BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report
Thu, Oct 29 -
EDGAR Online | | • | NBIX | | Neurocrine Biosciences, Inc. Q3 2009 Earnings Conference Call
Thu, Oct 29 -
at Seeking Alpha | | • | NBIX | | NEUROCRINE BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
Wed, Oct 28 -
EDGAR Online | | | All Headlines for these symbols... |
|
|
|
0.29% Nasdaq 
0.06 (1.76%) 
Competitors
